These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16543951)

  • 1. Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.
    Stüve O; Youssef S; Weber MS; Nessler S; von Büdingen HC; Hemmer B; Prod'homme T; Sobel RA; Steinman L; Zamvil SS
    J Clin Invest; 2006 Apr; 116(4):1037-44. PubMed ID: 16543951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
    Li Z; Chen L; Niu X; Liu J; Ping M; Li R; Xie X; Guo L
    J Neuroimmunol; 2012 Sep; 250(1-2):9-17. PubMed ID: 22673299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
    Abtahi Froushani SM; Delirezh N; Hobbenaghi R; Mosayebi G
    Immunol Invest; 2014; 43(1):54-68. PubMed ID: 24063549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of atorvastatin in multiple sclerosis].
    Koh CS
    Nihon Rinsho; 2003 Aug; 61(8):1455-60. PubMed ID: 12962038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
    Weber MS; Prod'homme T; Youssef S; Dunn SE; Steinman L; Zamvil SS
    J Neuroinflammation; 2014 Feb; 11():29. PubMed ID: 24498870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
    Aktas O; Waiczies S; Smorodchenko A; Dorr J; Seeger B; Prozorovski T; Sallach S; Endres M; Brocke S; Nitsch R; Zipp F
    J Exp Med; 2003 Mar; 197(6):725-33. PubMed ID: 12629065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin and glatiramer acetate: new hope in MS?
    Bradbury J
    Lancet Neurol; 2006 May; 5(5):386-7. PubMed ID: 16639832
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Schrempf W; Ziemssen T
    Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
    Dunn SE; Youssef S; Goldstein MJ; Prod'homme T; Weber MS; Zamvil SS; Steinman L
    J Exp Med; 2006 Feb; 203(2):401-12. PubMed ID: 16476765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.
    Kim HJ; Ifergan I; Antel JP; Seguin R; Duddy M; Lapierre Y; Jalili F; Bar-Or A
    J Immunol; 2004 Jun; 172(11):7144-53. PubMed ID: 15153538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W; Li WM; Gao C; Sun NL
    J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis.
    Aktunc E; Kayhan B; Arasli M; Gun BD; Barut F
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):667-75. PubMed ID: 21428710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling multiple sclerosis.
    Wekerle H
    Nature; 2002 Nov; 420(6911):39-40. PubMed ID: 12422206
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
    Arnon R; Aharoni R
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.